Hospira, Inc. recalls Ondansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, Rx only, Sterile, NDC 0409-4755-03, Hospira
Recalled August 14, 2013 · FDA recall D-851-2013 · Hospira
Hazard
Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot · FDA Class II
Units
340,600 vials
Sold at
Nationwide
Description
Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot
Product
Ondansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, Rx only, Sterile, NDC 0409-4755-03, Hospira, Inc, Lake Forest, IL 60045.
Manufacturer(s)
Hospira, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →